Skip to main navigation Skip to search Skip to main content

A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ATM-027 IN PATIENTS WITH MULTIPLE SCLEROSIS ....

Project: Research

Project Details

StatusFinished
Effective start/end date08/6/99 → 08/5/01

Funding

  • AstraZeneca LP: $4,982.40